Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ZNTL. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 111 institutions reported holding ZNTL, with 47.4 million shares worth $228.9 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 4,002,882 | $19M | INCREASED |
| 5am Venture Management | 3,947,913 | $19M | UNCHANGED |
| BlackRock | 3,753,525 | $18M | INCREASED |
| Squadron Capital Management | 3,700,000 | $18M | INCREASED |
| Two Sigma Investments | 3,024,936 | $15M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Zentalis Pharmaceuticals, Inc. Common Stock on SentiSense.